nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD1—Crohn's disease	0.0119	0.0223	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—NOD1—Crohn's disease	0.0117	0.0219	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—NOD1—Crohn's disease	0.0112	0.0211	CbGpPWpGaD
Imiquimod—Lymphoma—Azathioprine—Crohn's disease	0.0102	0.0224	CcSEcCtD
Imiquimod—Skin hyperpigmentation—Mercaptopurine—Crohn's disease	0.01	0.0221	CcSEcCtD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD1—Crohn's disease	0.009	0.0169	CbGpPWpGaD
Imiquimod—Cyst—Mercaptopurine—Crohn's disease	0.00893	0.0196	CcSEcCtD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—NOD1—Crohn's disease	0.00883	0.0166	CbGpPWpGaD
Imiquimod—Rectal tenesmus—Mesalazine—Crohn's disease	0.0087	0.0191	CcSEcCtD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—NOD1—Crohn's disease	0.00852	0.016	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RIPK2—Crohn's disease	0.00829	0.0155	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—RIPK2—Crohn's disease	0.00814	0.0153	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—NOD1—Crohn's disease	0.00799	0.015	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—RIPK2—Crohn's disease	0.00785	0.0147	CbGpPWpGaD
Imiquimod—Bacterial infection—Azathioprine—Crohn's disease	0.00771	0.0169	CcSEcCtD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TAB1—Crohn's disease	0.00765	0.0143	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL12B—Crohn's disease	0.00758	0.0142	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—Crohn's disease	0.00751	0.0141	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—TAB1—Crohn's disease	0.00751	0.0141	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—NOD2—Crohn's disease	0.00738	0.0138	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—TAB1—Crohn's disease	0.00725	0.0136	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—NOD2—Crohn's disease	0.00712	0.0134	CbGpPWpGaD
Imiquimod—Proctalgia—Mesalazine—Crohn's disease	0.00691	0.0152	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TAB1—Crohn's disease	0.00667	0.0125	CbGpPWpGaD
Imiquimod—Rectal disorder—Mesalazine—Crohn's disease	0.00661	0.0145	CcSEcCtD
Imiquimod—Ulcer—Mercaptopurine—Crohn's disease	0.00631	0.0139	CcSEcCtD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RIPK2—Crohn's disease	0.00628	0.0118	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—RIPK2—Crohn's disease	0.00617	0.0116	CbGpPWpGaD
Imiquimod—Anorectal disorder—Mesalazine—Crohn's disease	0.00616	0.0135	CcSEcCtD
Imiquimod—TLR7—Toll-Like Receptors Cascades—NOD1—Crohn's disease	0.00606	0.0114	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—RIPK2—Crohn's disease	0.00595	0.0112	CbGpPWpGaD
Imiquimod—Anorectal discomfort—Mesalazine—Crohn's disease	0.00593	0.013	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL12B—Crohn's disease	0.00592	0.0111	CbGpPWpGaD
Imiquimod—Local reaction—Mesalazine—Crohn's disease	0.00585	0.0129	CcSEcCtD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TAB1—Crohn's disease	0.0058	0.0109	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—UBE2D1—Crohn's disease	0.00576	0.0108	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL12B—Crohn's disease	0.00574	0.0108	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—Crohn's disease	0.0057	0.0107	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—TAB1—Crohn's disease	0.00569	0.0107	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—NOD2—Crohn's disease	0.00559	0.0105	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—RIPK2—Crohn's disease	0.00558	0.0105	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—TAB1—Crohn's disease	0.00549	0.0103	CbGpPWpGaD
Imiquimod—Platelet count decreased—Mesalazine—Crohn's disease	0.00545	0.012	CcSEcCtD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—NOD2—Crohn's disease	0.0054	0.0101	CbGpPWpGaD
Imiquimod—Cyst—Azathioprine—Crohn's disease	0.00532	0.0117	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TAB1—Crohn's disease	0.00521	0.00977	CbGpPWpGaD
Imiquimod—Psoriasis—Mesalazine—Crohn's disease	0.00516	0.0113	CcSEcCtD
Imiquimod—TLR8—Toll-Like Receptors Cascades—TAB1—Crohn's disease	0.00515	0.00966	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—NOD2—Crohn's disease	0.00506	0.00949	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TAB1—Crohn's disease	0.00506	0.00948	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—SOCS1—Crohn's disease	0.00482	0.00905	CbGpPWpGaD
Imiquimod—Pharyngolaryngeal pain—Mesalazine—Crohn's disease	0.0048	0.0105	CcSEcCtD
Imiquimod—TLR8—Toll-Like Receptors Cascades—SOCS1—Crohn's disease	0.00477	0.00894	CbGpPWpGaD
Imiquimod—Laryngeal pain—Mesalazine—Crohn's disease	0.00475	0.0104	CcSEcCtD
Imiquimod—Herpes zoster—Azathioprine—Crohn's disease	0.00472	0.0104	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL12B—Crohn's disease	0.00448	0.00841	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TLR4—Crohn's disease	0.00447	0.00838	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—UBE2D1—Crohn's disease	0.00436	0.00818	CbGpPWpGaD
Imiquimod—Rigors—Azathioprine—Crohn's disease	0.00436	0.00957	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—DEFA5—Crohn's disease	0.00435	0.00816	CbGpPWpGaD
Imiquimod—Rash erythematous—Mesalazine—Crohn's disease	0.00423	0.0093	CcSEcCtD
Imiquimod—TLR7—Toll-Like Receptors Cascades—RIPK2—Crohn's disease	0.00423	0.00793	CbGpPWpGaD
Imiquimod—TLR8—lymphoid tissue—Crohn's disease	0.00418	0.364	CbGeAlD
Imiquimod—Feeling hot—Mesalazine—Crohn's disease	0.00413	0.00907	CcSEcCtD
Imiquimod—Hyperaesthesia—Mesalazine—Crohn's disease	0.00413	0.00907	CcSEcCtD
Imiquimod—Rash pustular—Mesalazine—Crohn's disease	0.00406	0.00893	CcSEcCtD
Imiquimod—Leukoderma—Prednisone—Crohn's disease	0.00403	0.00886	CcSEcCtD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TYK2—Crohn's disease	0.00399	0.00748	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TAB1—Crohn's disease	0.00395	0.0074	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ERAP2—Crohn's disease	0.00394	0.00738	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—TYK2—Crohn's disease	0.00392	0.00734	CbGpPWpGaD
Imiquimod—Breast disorder—Mercaptopurine—Crohn's disease	0.00392	0.0086	CcSEcCtD
Imiquimod—TLR7—Toll-Like Receptors Cascades—TAB1—Crohn's disease	0.0039	0.00732	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—NOD2—Crohn's disease	0.00383	0.00719	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JAK2—Crohn's disease	0.00381	0.00714	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—TYK2—Crohn's disease	0.00378	0.00709	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—JAK2—Crohn's disease	0.00374	0.00701	CbGpPWpGaD
Imiquimod—Tenderness—Mesalazine—Crohn's disease	0.00371	0.00816	CcSEcCtD
Imiquimod—Proteinuria—Mesalazine—Crohn's disease	0.00369	0.0081	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—SOCS1—Crohn's disease	0.00366	0.00686	CbGpPWpGaD
Imiquimod—Protein urine present—Mesalazine—Crohn's disease	0.00364	0.00799	CcSEcCtD
Imiquimod—TLR7—Toll-Like Receptors Cascades—SOCS1—Crohn's disease	0.00361	0.00678	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—JAK2—Crohn's disease	0.00361	0.00676	CbGpPWpGaD
Imiquimod—Pancytopenia—Mercaptopurine—Crohn's disease	0.00356	0.00782	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—CARD9—Crohn's disease	0.00355	0.00665	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TLR4—Crohn's disease	0.00349	0.00654	CbGpPWpGaD
Imiquimod—Gout—Mesalazine—Crohn's disease	0.00347	0.00762	CcSEcCtD
Imiquimod—TLR8—Toll-Like Receptors Cascades—TLR4—Crohn's disease	0.00345	0.00647	CbGpPWpGaD
Imiquimod—Hepatic enzyme increased—Mesalazine—Crohn's disease	0.00343	0.00753	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TLR4—Crohn's disease	0.00339	0.00635	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—DEFA5—Crohn's disease	0.0033	0.00619	CbGpPWpGaD
Imiquimod—Vaginal inflammation—Mesalazine—Crohn's disease	0.00324	0.00712	CcSEcCtD
Imiquimod—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00316	0.00694	CcSEcCtD
Imiquimod—Influenza like illness—Mesalazine—Crohn's disease	0.00315	0.00691	CcSEcCtD
Imiquimod—TLR8—Immune System—MADCAM1—Crohn's disease	0.00315	0.0059	CbGpPWpGaD
Imiquimod—Skin exfoliation—Mesalazine—Crohn's disease	0.00309	0.0068	CcSEcCtD
Imiquimod—Vaginal infection—Mesalazine—Crohn's disease	0.00306	0.00672	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—CXCL8—Crohn's disease	0.00303	0.00568	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TYK2—Crohn's disease	0.00302	0.00567	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ERAP2—Crohn's disease	0.00298	0.00559	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—TYK2—Crohn's disease	0.00297	0.00557	CbGpPWpGaD
Imiquimod—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00296	0.00649	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL1B—Crohn's disease	0.00291	0.00545	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JAK2—Crohn's disease	0.00288	0.00541	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—TYK2—Crohn's disease	0.00286	0.00537	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ICOSLG—Crohn's disease	0.00285	0.00533	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—JAK2—Crohn's disease	0.00283	0.00531	CbGpPWpGaD
Imiquimod—Lymphadenopathy—Mesalazine—Crohn's disease	0.00276	0.00606	CcSEcCtD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—JAK2—Crohn's disease	0.00273	0.00512	CbGpPWpGaD
Imiquimod—Immune system disorder—Mercaptopurine—Crohn's disease	0.00271	0.00595	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CARD9—Crohn's disease	0.00269	0.00504	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—TYK2—Crohn's disease	0.00269	0.00504	CbGpPWpGaD
Imiquimod—Alopecia—Mercaptopurine—Crohn's disease	0.00265	0.00582	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TLR4—Crohn's disease	0.00264	0.00496	CbGpPWpGaD
Imiquimod—TLR7—lymphoid tissue—Crohn's disease	0.00264	0.23	CbGeAlD
Imiquimod—Eczema—Mesalazine—Crohn's disease	0.00262	0.00575	CcSEcCtD
Imiquimod—TLR7—Toll-Like Receptors Cascades—TLR4—Crohn's disease	0.00261	0.0049	CbGpPWpGaD
Imiquimod—Malnutrition—Mercaptopurine—Crohn's disease	0.00261	0.00573	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—NOD1—Crohn's disease	0.00259	0.00485	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—JAK2—Crohn's disease	0.00256	0.00481	CbGpPWpGaD
Imiquimod—TLR8—Immune System—DEFA5—Crohn's disease	0.00254	0.00475	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IFNGR2—Crohn's disease	0.00254	0.00475	CbGpPWpGaD
Imiquimod—Atrial fibrillation—Mesalazine—Crohn's disease	0.00248	0.00545	CcSEcCtD
Imiquimod—Arthritis—Mesalazine—Crohn's disease	0.00242	0.00532	CcSEcCtD
Imiquimod—Lethargy—Mesalazine—Crohn's disease	0.0024	0.00527	CcSEcCtD
Imiquimod—TLR7—Immune System—MADCAM1—Crohn's disease	0.00238	0.00447	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—CXCL8—Crohn's disease	0.00237	0.00444	CbGpPWpGaD
Imiquimod—TLR8—lymph node—Crohn's disease	0.00236	0.206	CbGeAlD
Imiquimod—TLR8—Innate Immune System—CCR6—Crohn's disease	0.00235	0.00441	CbGpPWpGaD
Imiquimod—Migraine—Mesalazine—Crohn's disease	0.00232	0.00509	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—CXCL8—Crohn's disease	0.0023	0.00431	CbGpPWpGaD
Imiquimod—Face oedema—Mesalazine—Crohn's disease	0.00227	0.00499	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL1B—Crohn's disease	0.00227	0.00426	CbGpPWpGaD
Imiquimod—Arthralgia—Mercaptopurine—Crohn's disease	0.00222	0.00488	CcSEcCtD
Imiquimod—Fungal infection—Prednisone—Crohn's disease	0.00222	0.00488	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00221	0.00485	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL1B—Crohn's disease	0.0022	0.00413	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ICOSLG—Crohn's disease	0.00216	0.00404	CbGpPWpGaD
Imiquimod—Oedema—Mercaptopurine—Crohn's disease	0.00213	0.00468	CcSEcCtD
Imiquimod—Breast disorder—Mesalazine—Crohn's disease	0.00213	0.00467	CcSEcCtD
Imiquimod—Pancytopenia—Azathioprine—Crohn's disease	0.00212	0.00466	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TNF—Crohn's disease	0.00211	0.00396	CbGpPWpGaD
Imiquimod—Skin disorder—Mercaptopurine—Crohn's disease	0.00207	0.00455	CcSEcCtD
Imiquimod—TLR8—Immune System—CARD9—Crohn's disease	0.00207	0.00388	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—TYK2—Crohn's disease	0.00204	0.00382	CbGpPWpGaD
Imiquimod—Influenza—Mesalazine—Crohn's disease	0.00203	0.00447	CcSEcCtD
Imiquimod—Anorexia—Mercaptopurine—Crohn's disease	0.00203	0.00446	CcSEcCtD
Imiquimod—Infestation—Azathioprine—Crohn's disease	0.00199	0.00437	CcSEcCtD
Imiquimod—Infestation NOS—Azathioprine—Crohn's disease	0.00199	0.00437	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00197	0.00433	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—NOD1—Crohn's disease	0.00196	0.00368	CbGpPWpGaD
Imiquimod—Bronchitis—Mesalazine—Crohn's disease	0.00196	0.0043	CcSEcCtD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Crohn's disease	0.00195	0.00366	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—JAK2—Crohn's disease	0.00194	0.00364	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00194	0.00426	CcSEcCtD
Imiquimod—Pancytopenia—Mesalazine—Crohn's disease	0.00193	0.00424	CcSEcCtD
Imiquimod—TLR7—Immune System—DEFA5—Crohn's disease	0.00192	0.0036	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IFNGR2—Crohn's disease	0.00192	0.0036	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—IL6—Crohn's disease	0.00192	0.00359	CbGpPWpGaD
Imiquimod—Dysuria—Mesalazine—Crohn's disease	0.0019	0.00418	CcSEcCtD
Imiquimod—Viral infection—Prednisone—Crohn's disease	0.0019	0.00417	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00189	0.00415	CcSEcCtD
Imiquimod—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00188	0.00413	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—UBE2D1—Crohn's disease	0.00186	0.0035	CbGpPWpGaD
Imiquimod—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00186	0.00408	CcSEcCtD
Imiquimod—Decreased appetite—Mercaptopurine—Crohn's disease	0.00185	0.00407	CcSEcCtD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—IL6—Crohn's disease	0.00185	0.00347	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00184	0.00404	CcSEcCtD
Imiquimod—Infestation—Mesalazine—Crohn's disease	0.00181	0.00398	CcSEcCtD
Imiquimod—Infestation NOS—Mesalazine—Crohn's disease	0.00181	0.00398	CcSEcCtD
Imiquimod—Ulcer—Prednisone—Crohn's disease	0.00181	0.00398	CcSEcCtD
Imiquimod—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00181	0.00398	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—RIPK2—Crohn's disease	0.00181	0.00339	CbGpPWpGaD
Imiquimod—Depression—Mesalazine—Crohn's disease	0.00181	0.00397	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.0018	0.00395	CcSEcCtD
Imiquimod—Haemoglobin—Azathioprine—Crohn's disease	0.0018	0.00394	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CXCL8—Crohn's disease	0.00179	0.00336	CbGpPWpGaD
Imiquimod—Haemorrhage—Azathioprine—Crohn's disease	0.00179	0.00392	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CCR6—Crohn's disease	0.00178	0.00334	CbGpPWpGaD
Imiquimod—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00178	0.0039	CcSEcCtD
Imiquimod—Urinary tract infection—Mesalazine—Crohn's disease	0.00176	0.00387	CcSEcCtD
Imiquimod—Conjunctivitis—Mesalazine—Crohn's disease	0.00176	0.00387	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL1B—Crohn's disease	0.00172	0.00322	CbGpPWpGaD
Imiquimod—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00171	0.00377	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—RASGRP1—Crohn's disease	0.00171	0.0032	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	0.0017	0.00319	CbGpPWpGaD
Imiquimod—Sinusitis—Mesalazine—Crohn's disease	0.0017	0.00374	CcSEcCtD
Imiquimod—Erythema multiforme—Azathioprine—Crohn's disease	0.00169	0.00371	CcSEcCtD
Imiquimod—Body temperature increased—Mercaptopurine—Crohn's disease	0.00168	0.0037	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—TAB1—Crohn's disease	0.00167	0.00313	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	0.00165	0.00309	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—NOD2—Crohn's disease	0.00164	0.00307	CbGpPWpGaD
Imiquimod—Skin exfoliation—Prednisone—Crohn's disease	0.00164	0.0036	CcSEcCtD
Imiquimod—Haemoglobin—Mesalazine—Crohn's disease	0.00164	0.00359	CcSEcCtD
Imiquimod—Rhinitis—Mesalazine—Crohn's disease	0.00163	0.00358	CcSEcCtD
Imiquimod—Haemorrhage—Mesalazine—Crohn's disease	0.00163	0.00358	CcSEcCtD
Imiquimod—Pharyngitis—Mesalazine—Crohn's disease	0.00162	0.00355	CcSEcCtD
Imiquimod—Immune system disorder—Azathioprine—Crohn's disease	0.00161	0.00355	CcSEcCtD
Imiquimod—Mediastinal disorder—Azathioprine—Crohn's disease	0.00161	0.00354	CcSEcCtD
Imiquimod—Urinary tract disorder—Mesalazine—Crohn's disease	0.00161	0.00353	CcSEcCtD
Imiquimod—Chills—Azathioprine—Crohn's disease	0.0016	0.00352	CcSEcCtD
Imiquimod—Connective tissue disorder—Mesalazine—Crohn's disease	0.0016	0.00351	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TNF—Crohn's disease	0.0016	0.003	CbGpPWpGaD
Imiquimod—Arrhythmia—Azathioprine—Crohn's disease	0.0016	0.00351	CcSEcCtD
Imiquimod—Urethral disorder—Mesalazine—Crohn's disease	0.0016	0.0035	CcSEcCtD
Imiquimod—Alopecia—Azathioprine—Crohn's disease	0.00158	0.00347	CcSEcCtD
Imiquimod—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00157	0.00345	CcSEcCtD
Imiquimod—CYP1A2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00157	0.00294	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CARD9—Crohn's disease	0.00157	0.00294	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—SOCS1—Crohn's disease	0.00154	0.0029	CbGpPWpGaD
Imiquimod—Erythema multiforme—Mesalazine—Crohn's disease	0.00154	0.00338	CcSEcCtD
Imiquimod—Pulmonary oedema—Prednisone—Crohn's disease	0.00153	0.00335	CcSEcCtD
Imiquimod—Eye disorder—Mesalazine—Crohn's disease	0.00152	0.00334	CcSEcCtD
Imiquimod—Tinnitus—Mesalazine—Crohn's disease	0.00152	0.00333	CcSEcCtD
Imiquimod—TLR8—Immune System—NOD1—Crohn's disease	0.00151	0.00283	CbGpPWpGaD
Imiquimod—TLR7—lymph node—Crohn's disease	0.00149	0.13	CbGeAlD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Crohn's disease	0.00148	0.00277	CbGpPWpGaD
Imiquimod—Angiopathy—Mesalazine—Crohn's disease	0.00148	0.00324	CcSEcCtD
Imiquimod—Immune system disorder—Mesalazine—Crohn's disease	0.00147	0.00323	CcSEcCtD
Imiquimod—Mediastinal disorder—Mesalazine—Crohn's disease	0.00147	0.00322	CcSEcCtD
Imiquimod—Chills—Mesalazine—Crohn's disease	0.00146	0.00321	CcSEcCtD
Imiquimod—Diarrhoea—Mercaptopurine—Crohn's disease	0.00146	0.0032	CcSEcCtD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—IL6—Crohn's disease	0.00145	0.00272	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Azathioprine—Crohn's disease	0.00144	0.00317	CcSEcCtD
Imiquimod—Alopecia—Mesalazine—Crohn's disease	0.00144	0.00316	CcSEcCtD
Imiquimod—Mental disorder—Mesalazine—Crohn's disease	0.00143	0.00313	CcSEcCtD
Imiquimod—Erythema—Mesalazine—Crohn's disease	0.00142	0.00311	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—UBE2D1—Crohn's disease	0.00141	0.00265	CbGpPWpGaD
Imiquimod—Malaise—Azathioprine—Crohn's disease	0.0014	0.00308	CcSEcCtD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—Crohn's disease	0.0014	0.00263	CbGpPWpGaD
Imiquimod—Back pain—Mesalazine—Crohn's disease	0.00137	0.00301	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—RIPK2—Crohn's disease	0.00137	0.00257	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CCR6—Crohn's disease	0.00137	0.00257	CbGpPWpGaD
Imiquimod—Vomiting—Mercaptopurine—Crohn's disease	0.00135	0.00298	CcSEcCtD
Imiquimod—Injury—Prednisone—Crohn's disease	0.00135	0.00297	CcSEcCtD
Imiquimod—Rash—Mercaptopurine—Crohn's disease	0.00134	0.00295	CcSEcCtD
Imiquimod—Dermatitis—Mercaptopurine—Crohn's disease	0.00134	0.00295	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	0.00133	0.00249	CbGpPWpGaD
Imiquimod—Arthralgia—Azathioprine—Crohn's disease	0.00132	0.00291	CcSEcCtD
Imiquimod—Myalgia—Azathioprine—Crohn's disease	0.00132	0.00291	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00131	0.00289	CcSEcCtD
Imiquimod—Ill-defined disorder—Mesalazine—Crohn's disease	0.00131	0.00289	CcSEcCtD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IL6—Crohn's disease	0.00131	0.00246	CbGpPWpGaD
Imiquimod—Discomfort—Azathioprine—Crohn's disease	0.00131	0.00287	CcSEcCtD
Imiquimod—Angioedema—Mesalazine—Crohn's disease	0.00129	0.00284	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—RASGRP1—Crohn's disease	0.00129	0.00242	CbGpPWpGaD
Imiquimod—Purpura—Prednisone—Crohn's disease	0.00129	0.00284	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	0.00129	0.00242	CbGpPWpGaD
Imiquimod—Malaise—Mesalazine—Crohn's disease	0.00128	0.00281	CcSEcCtD
Imiquimod—Cardiac failure—Prednisone—Crohn's disease	0.00128	0.0028	CcSEcCtD
Imiquimod—Syncope—Mesalazine—Crohn's disease	0.00127	0.00279	CcSEcCtD
Imiquimod—Lethargy—Prednisone—Crohn's disease	0.00127	0.00279	CcSEcCtD
Imiquimod—Nausea—Mercaptopurine—Crohn's disease	0.00127	0.00278	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—TAB1—Crohn's disease	0.00126	0.00237	CbGpPWpGaD
Imiquimod—Infection—Azathioprine—Crohn's disease	0.00126	0.00277	CcSEcCtD
Imiquimod—TLR8—Immune System—PTPN2—Crohn's disease	0.00125	0.00235	CbGpPWpGaD
Imiquimod—Palpitations—Mesalazine—Crohn's disease	0.00125	0.00275	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	0.00125	0.00234	CbGpPWpGaD
Imiquimod—Loss of consciousness—Mesalazine—Crohn's disease	0.00125	0.00274	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—NOD2—Crohn's disease	0.00124	0.00233	CbGpPWpGaD
Imiquimod—TLR8—Immune System—RBX1—Crohn's disease	0.00124	0.00232	CbGpPWpGaD
Imiquimod—Cough—Mesalazine—Crohn's disease	0.00124	0.00272	CcSEcCtD
Imiquimod—Skin disorder—Azathioprine—Crohn's disease	0.00123	0.00271	CcSEcCtD
Imiquimod—Hypertension—Mesalazine—Crohn's disease	0.00122	0.00269	CcSEcCtD
Imiquimod—Myalgia—Mesalazine—Crohn's disease	0.00121	0.00265	CcSEcCtD
Imiquimod—Chest pain—Mesalazine—Crohn's disease	0.00121	0.00265	CcSEcCtD
Imiquimod—Arthralgia—Mesalazine—Crohn's disease	0.00121	0.00265	CcSEcCtD
Imiquimod—Anxiety—Mesalazine—Crohn's disease	0.0012	0.00264	CcSEcCtD
Imiquimod—Face oedema—Prednisone—Crohn's disease	0.0012	0.00264	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.0012	0.00263	CcSEcCtD
Imiquimod—Discomfort—Mesalazine—Crohn's disease	0.00119	0.00262	CcSEcCtD
Imiquimod—Irritability—Prednisone—Crohn's disease	0.00119	0.00261	CcSEcCtD
Imiquimod—Dry mouth—Mesalazine—Crohn's disease	0.00118	0.00259	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—SOCS1—Crohn's disease	0.00117	0.0022	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CRP—Crohn's disease	0.00116	0.00218	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00116	0.00254	CcSEcCtD
Imiquimod—Oedema—Mesalazine—Crohn's disease	0.00116	0.00254	CcSEcCtD
Imiquimod—Infection—Mesalazine—Crohn's disease	0.00115	0.00252	CcSEcCtD
Imiquimod—TLR7—Immune System—NOD1—Crohn's disease	0.00114	0.00214	CbGpPWpGaD
Imiquimod—Shock—Mesalazine—Crohn's disease	0.00114	0.0025	CcSEcCtD
Imiquimod—Nervous system disorder—Mesalazine—Crohn's disease	0.00113	0.00249	CcSEcCtD
Imiquimod—Tachycardia—Mesalazine—Crohn's disease	0.00113	0.00248	CcSEcCtD
Imiquimod—Skin disorder—Mesalazine—Crohn's disease	0.00112	0.00247	CcSEcCtD
Imiquimod—Hyperhidrosis—Mesalazine—Crohn's disease	0.00112	0.00246	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—TLR4—Crohn's disease	0.00112	0.00209	CbGpPWpGaD
Imiquimod—Anorexia—Mesalazine—Crohn's disease	0.0011	0.00242	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.0011	0.00241	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.00109	0.00205	CbGpPWpGaD
Imiquimod—TLR8—Immune System—UBE2D1—Crohn's disease	0.00109	0.00204	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00105	0.00231	CcSEcCtD
Imiquimod—TLR8—Immune System—RIPK2—Crohn's disease	0.00105	0.00197	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ITGA4—Crohn's disease	0.00105	0.00197	CbGpPWpGaD
Imiquimod—Sweating increased—Prednisone—Crohn's disease	0.00105	0.0023	CcSEcCtD
Imiquimod—Feeling abnormal—Azathioprine—Crohn's disease	0.00105	0.0023	CcSEcCtD
Imiquimod—Insomnia—Mesalazine—Crohn's disease	0.00105	0.0023	CcSEcCtD
Imiquimod—Paraesthesia—Mesalazine—Crohn's disease	0.00104	0.00228	CcSEcCtD
Imiquimod—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00104	0.00228	CcSEcCtD
Imiquimod—TLR7—Immune System—CCR6—Crohn's disease	0.00104	0.00195	CbGpPWpGaD
Imiquimod—Dyspnoea—Mesalazine—Crohn's disease	0.00103	0.00226	CcSEcCtD
Imiquimod—Somnolence—Mesalazine—Crohn's disease	0.00103	0.00226	CcSEcCtD
Imiquimod—TLR8—Immune System—IL3—Crohn's disease	0.00103	0.00193	CbGpPWpGaD
Imiquimod—Dyspepsia—Mesalazine—Crohn's disease	0.00102	0.00224	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	0.00101	0.00189	CbGpPWpGaD
Imiquimod—Decreased appetite—Mesalazine—Crohn's disease	0.00101	0.00221	CcSEcCtD
Imiquimod—Body temperature increased—Azathioprine—Crohn's disease	0.001	0.0022	CcSEcCtD
Imiquimod—Abdominal pain—Azathioprine—Crohn's disease	0.001	0.0022	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000998	0.00219	CcSEcCtD
Imiquimod—Fatigue—Mesalazine—Crohn's disease	0.000997	0.00219	CcSEcCtD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—Crohn's disease	0.000996	0.00187	CbGpPWpGaD
Imiquimod—TLR8—Immune System—RASGRP1—Crohn's disease	0.000993	0.00186	CbGpPWpGaD
Imiquimod—Erectile dysfunction—Prednisone—Crohn's disease	0.000991	0.00218	CcSEcCtD
Imiquimod—TLR8—Immune System—CD79A—Crohn's disease	0.00099	0.00186	CbGpPWpGaD
Imiquimod—Pain—Mesalazine—Crohn's disease	0.000989	0.00217	CcSEcCtD
Imiquimod—TLR8—Immune System—TAB1—Crohn's disease	0.000972	0.00182	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.000967	0.00181	CbGpPWpGaD
Imiquimod—Depression—Prednisone—Crohn's disease	0.000956	0.0021	CcSEcCtD
Imiquimod—TLR8—Immune System—NOD2—Crohn's disease	0.000955	0.00179	CbGpPWpGaD
Imiquimod—Feeling abnormal—Mesalazine—Crohn's disease	0.000953	0.00209	CcSEcCtD
Imiquimod—TLR7—Immune System—PTPN2—Crohn's disease	0.000949	0.00178	CbGpPWpGaD
Imiquimod—Acute coronary syndrome—Prednisone—Crohn's disease	0.000946	0.00208	CcSEcCtD
Imiquimod—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000945	0.00208	CcSEcCtD
Imiquimod—Neuropathy peripheral—Prednisone—Crohn's disease	0.00094	0.00207	CcSEcCtD
Imiquimod—Myocardial infarction—Prednisone—Crohn's disease	0.00094	0.00207	CcSEcCtD
Imiquimod—TLR7—Immune System—RBX1—Crohn's disease	0.000939	0.00176	CbGpPWpGaD
Imiquimod—Hypersensitivity—Azathioprine—Crohn's disease	0.000935	0.00205	CcSEcCtD
Imiquimod—Urticaria—Mesalazine—Crohn's disease	0.000918	0.00202	CcSEcCtD
Imiquimod—Body temperature increased—Mesalazine—Crohn's disease	0.000914	0.00201	CcSEcCtD
Imiquimod—Abdominal pain—Mesalazine—Crohn's disease	0.000914	0.00201	CcSEcCtD
Imiquimod—TLR8—Immune System—SOCS1—Crohn's disease	0.0009	0.00169	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CRP—Crohn's disease	0.000883	0.00166	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TYK2—Crohn's disease	0.00087	0.00163	CbGpPWpGaD
Imiquimod—Diarrhoea—Azathioprine—Crohn's disease	0.000868	0.00191	CcSEcCtD
Imiquimod—Haemoglobin—Prednisone—Crohn's disease	0.000865	0.0019	CcSEcCtD
Imiquimod—Haemorrhage—Prednisone—Crohn's disease	0.000861	0.00189	CcSEcCtD
Imiquimod—Hypersensitivity—Mesalazine—Crohn's disease	0.000852	0.00187	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—TLR4—Crohn's disease	0.000846	0.00159	CbGpPWpGaD
Imiquimod—Connective tissue disorder—Prednisone—Crohn's disease	0.000846	0.00186	CcSEcCtD
Imiquimod—Dizziness—Azathioprine—Crohn's disease	0.000839	0.00184	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—JAK2—Crohn's disease	0.00083	0.00156	CbGpPWpGaD
Imiquimod—Asthenia—Mesalazine—Crohn's disease	0.00083	0.00182	CcSEcCtD
Imiquimod—TLR7—Immune System—UBE2D1—Crohn's disease	0.000823	0.00154	CbGpPWpGaD
Imiquimod—Pruritus—Mesalazine—Crohn's disease	0.000818	0.0018	CcSEcCtD
Imiquimod—TLR8—Immune System—IL18—Crohn's disease	0.00081	0.00152	CbGpPWpGaD
Imiquimod—Vomiting—Azathioprine—Crohn's disease	0.000807	0.00177	CcSEcCtD
Imiquimod—Eye disorder—Prednisone—Crohn's disease	0.000805	0.00177	CcSEcCtD
Imiquimod—Rash—Azathioprine—Crohn's disease	0.0008	0.00176	CcSEcCtD
Imiquimod—Dermatitis—Azathioprine—Crohn's disease	0.0008	0.00176	CcSEcCtD
Imiquimod—Flushing—Prednisone—Crohn's disease	0.000799	0.00176	CcSEcCtD
Imiquimod—TLR7—Immune System—ITGA4—Crohn's disease	0.000798	0.0015	CbGpPWpGaD
Imiquimod—TLR7—Immune System—RIPK2—Crohn's disease	0.000798	0.0015	CbGpPWpGaD
Imiquimod—Headache—Azathioprine—Crohn's disease	0.000795	0.00175	CcSEcCtD
Imiquimod—Diarrhoea—Mesalazine—Crohn's disease	0.000791	0.00174	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—CD4—Crohn's disease	0.000787	0.00148	CbGpPWpGaD
Imiquimod—Angiopathy—Prednisone—Crohn's disease	0.000781	0.00172	CcSEcCtD
Imiquimod—TLR7—Immune System—IL3—Crohn's disease	0.000778	0.00146	CbGpPWpGaD
Imiquimod—Immune system disorder—Prednisone—Crohn's disease	0.000778	0.00171	CcSEcCtD
Imiquimod—Arrhythmia—Prednisone—Crohn's disease	0.000769	0.00169	CcSEcCtD
Imiquimod—Dizziness—Mesalazine—Crohn's disease	0.000765	0.00168	CcSEcCtD
Imiquimod—Alopecia—Prednisone—Crohn's disease	0.000761	0.00167	CcSEcCtD
Imiquimod—Mental disorder—Prednisone—Crohn's disease	0.000754	0.00166	CcSEcCtD
Imiquimod—Nausea—Azathioprine—Crohn's disease	0.000754	0.00166	CcSEcCtD
Imiquimod—TLR7—Immune System—RASGRP1—Crohn's disease	0.000753	0.00141	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD79A—Crohn's disease	0.00075	0.00141	CbGpPWpGaD
Imiquimod—Malnutrition—Prednisone—Crohn's disease	0.00075	0.00165	CcSEcCtD
Imiquimod—Erythema—Prednisone—Crohn's disease	0.00075	0.00165	CcSEcCtD
Imiquimod—TLR7—Immune System—TAB1—Crohn's disease	0.000736	0.00138	CbGpPWpGaD
Imiquimod—Vomiting—Mesalazine—Crohn's disease	0.000735	0.00161	CcSEcCtD
Imiquimod—Rash—Mesalazine—Crohn's disease	0.000729	0.0016	CcSEcCtD
Imiquimod—Dermatitis—Mesalazine—Crohn's disease	0.000728	0.0016	CcSEcCtD
Imiquimod—Headache—Mesalazine—Crohn's disease	0.000724	0.00159	CcSEcCtD
Imiquimod—TLR7—Immune System—NOD2—Crohn's disease	0.000723	0.00136	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL2RA—Crohn's disease	0.000719	0.00135	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Prednisone—Crohn's disease	0.000695	0.00153	CcSEcCtD
Imiquimod—Agitation—Prednisone—Crohn's disease	0.000689	0.00151	CcSEcCtD
Imiquimod—Nausea—Mesalazine—Crohn's disease	0.000687	0.00151	CcSEcCtD
Imiquimod—Angioedema—Prednisone—Crohn's disease	0.000685	0.0015	CcSEcCtD
Imiquimod—TLR7—Immune System—SOCS1—Crohn's disease	0.000682	0.00128	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CRP—Crohn's disease	0.000679	0.00127	CbGpPWpGaD
Imiquimod—Malaise—Prednisone—Crohn's disease	0.000676	0.00148	CcSEcCtD
Imiquimod—Syncope—Prednisone—Crohn's disease	0.000672	0.00148	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—TYK2—Crohn's disease	0.000659	0.00124	CbGpPWpGaD
Imiquimod—Loss of consciousness—Prednisone—Crohn's disease	0.000659	0.00145	CcSEcCtD
Imiquimod—TLR8—Immune System—TLR4—Crohn's disease	0.000651	0.00122	CbGpPWpGaD
Imiquimod—Convulsion—Prednisone—Crohn's disease	0.000649	0.00143	CcSEcCtD
Imiquimod—Hypertension—Prednisone—Crohn's disease	0.000647	0.00142	CcSEcCtD
Imiquimod—Myalgia—Prednisone—Crohn's disease	0.000638	0.0014	CcSEcCtD
Imiquimod—Arthralgia—Prednisone—Crohn's disease	0.000638	0.0014	CcSEcCtD
Imiquimod—Anxiety—Prednisone—Crohn's disease	0.000636	0.0014	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000634	0.00139	CcSEcCtD
Imiquimod—Discomfort—Prednisone—Crohn's disease	0.00063	0.00139	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—JAK2—Crohn's disease	0.000629	0.00118	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ICAM1—Crohn's disease	0.000624	0.00117	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL18—Crohn's disease	0.000614	0.00115	CbGpPWpGaD
Imiquimod—Oedema—Prednisone—Crohn's disease	0.000612	0.00134	CcSEcCtD
Imiquimod—Infection—Prednisone—Crohn's disease	0.000608	0.00134	CcSEcCtD
Imiquimod—Shock—Prednisone—Crohn's disease	0.000602	0.00132	CcSEcCtD
Imiquimod—Nervous system disorder—Prednisone—Crohn's disease	0.0006	0.00132	CcSEcCtD
Imiquimod—Tachycardia—Prednisone—Crohn's disease	0.000597	0.00131	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CD4—Crohn's disease	0.000596	0.00112	CbGpPWpGaD
Imiquimod—Skin disorder—Prednisone—Crohn's disease	0.000594	0.00131	CcSEcCtD
Imiquimod—Hyperhidrosis—Prednisone—Crohn's disease	0.000591	0.0013	CcSEcCtD
Imiquimod—Anorexia—Prednisone—Crohn's disease	0.000583	0.00128	CcSEcCtD
Imiquimod—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	0.000576	0.00108	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000557	0.00122	CcSEcCtD
Imiquimod—Insomnia—Prednisone—Crohn's disease	0.000553	0.00122	CcSEcCtD
Imiquimod—Paraesthesia—Prednisone—Crohn's disease	0.000549	0.00121	CcSEcCtD
Imiquimod—TLR7—Immune System—IL2RA—Crohn's disease	0.000545	0.00102	CbGpPWpGaD
Imiquimod—Dyspepsia—Prednisone—Crohn's disease	0.000538	0.00118	CcSEcCtD
Imiquimod—Decreased appetite—Prednisone—Crohn's disease	0.000532	0.00117	CcSEcCtD
Imiquimod—Fatigue—Prednisone—Crohn's disease	0.000527	0.00116	CcSEcCtD
Imiquimod—TLR7—Immune System—CRP—Crohn's disease	0.000514	0.000964	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TYK2—Crohn's disease	0.000507	0.00095	CbGpPWpGaD
Imiquimod—Feeling abnormal—Prednisone—Crohn's disease	0.000504	0.00111	CcSEcCtD
Imiquimod—Gastrointestinal pain—Prednisone—Crohn's disease	0.0005	0.0011	CcSEcCtD
Imiquimod—TLR7—Immune System—TLR4—Crohn's disease	0.000493	0.000924	CbGpPWpGaD
Imiquimod—Urticaria—Prednisone—Crohn's disease	0.000486	0.00107	CcSEcCtD
Imiquimod—Abdominal pain—Prednisone—Crohn's disease	0.000484	0.00106	CcSEcCtD
Imiquimod—Body temperature increased—Prednisone—Crohn's disease	0.000484	0.00106	CcSEcCtD
Imiquimod—TLR8—Immune System—JAK2—Crohn's disease	0.000483	0.000907	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IFNG—Crohn's disease	0.000475	0.00089	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ICAM1—Crohn's disease	0.000473	0.000886	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.00047	0.000882	CbGpPWpGaD
Imiquimod—CYP1A2—digestive system—Crohn's disease	0.000469	0.0409	CbGeAlD
Imiquimod—TLR8—Immune System—CD4—Crohn's disease	0.000458	0.000859	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.000451	0.000846	CbGpPWpGaD
Imiquimod—Hypersensitivity—Prednisone—Crohn's disease	0.000451	0.00099	CcSEcCtD
Imiquimod—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000445	0.000833	CbGpPWpGaD
Imiquimod—Asthenia—Prednisone—Crohn's disease	0.000439	0.000964	CcSEcCtD
Imiquimod—Pruritus—Prednisone—Crohn's disease	0.000433	0.000951	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—IL6—Crohn's disease	0.000426	0.000798	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL1B—Crohn's disease	0.000423	0.000794	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000422	0.000791	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.00042	0.000787	CbGpPWpGaD
Imiquimod—Diarrhoea—Prednisone—Crohn's disease	0.000419	0.000919	CcSEcCtD
Imiquimod—Dizziness—Prednisone—Crohn's disease	0.000405	0.000889	CcSEcCtD
Imiquimod—Vomiting—Prednisone—Crohn's disease	0.000389	0.000854	CcSEcCtD
Imiquimod—Rash—Prednisone—Crohn's disease	0.000386	0.000847	CcSEcCtD
Imiquimod—Dermatitis—Prednisone—Crohn's disease	0.000385	0.000847	CcSEcCtD
Imiquimod—TLR7—Immune System—TYK2—Crohn's disease	0.000384	0.00072	CbGpPWpGaD
Imiquimod—Headache—Prednisone—Crohn's disease	0.000383	0.000842	CcSEcCtD
Imiquimod—TLR7—Immune System—JAK2—Crohn's disease	0.000366	0.000687	CbGpPWpGaD
Imiquimod—Nausea—Prednisone—Crohn's disease	0.000363	0.000798	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000362	0.000678	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IFNG—Crohn's disease	0.00036	0.000674	CbGpPWpGaD
Imiquimod—TLR8—Immune System—STAT3—Crohn's disease	0.000355	0.000665	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD4—Crohn's disease	0.000347	0.000651	CbGpPWpGaD
Imiquimod—CYP3A4—digestive system—Crohn's disease	0.000339	0.0296	CbGeAlD
Imiquimod—TLR7—Innate Immune System—IL6—Crohn's disease	0.000323	0.000605	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1B—Crohn's disease	0.000321	0.000602	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000307	0.000576	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000305	0.000571	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	0.000305	0.000571	CbGpPWpGaD
Imiquimod—TLR7—Immune System—STAT3—Crohn's disease	0.000269	0.000504	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6—Crohn's disease	0.000248	0.000465	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000239	0.000449	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000224	0.00042	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—Crohn's disease	0.000188	0.000352	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	0.000161	0.000302	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTMR3—Crohn's disease	0.000137	0.000257	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	0.000124	0.000233	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—FADS1—Crohn's disease	0.000107	0.0002	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTMR3—Crohn's disease	0.000106	0.000198	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPX4—Crohn's disease	9.99e-05	0.000187	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GCKR—Crohn's disease	9.65e-05	0.000181	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FADS1—Crohn's disease	8.23e-05	0.000154	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPX4—Crohn's disease	7.71e-05	0.000145	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GCKR—Crohn's disease	7.44e-05	0.00014	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.89e-05	0.000129	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.03e-05	0.000113	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALB—Crohn's disease	3.07e-05	5.76e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.69e-05	5.04e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALB—Crohn's disease	2.37e-05	4.44e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.07e-05	3.89e-05	CbGpPWpGaD
